Impact of biologicals on revision ESS numbers in CRSwNP in a tertiary care rhinology center
The advent of biologics reduced the number and percentage of severe uncontrolled CRSwNP patients undergoing revision ESS, in contrast to number and percentage of primary ESS.
Authors
- Judith Adriaenssens
- An-Sofie Viskens
- Elien Borgers
Institutions
- Air University (US)
- ENT and Allergy (US)
- Sacred Heart Hospital (US)
- KU Leuven (BE)
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/falgy.2025.1725159
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00